Health & Well-Being

Dr. Cato Laurencin, left, and physics professor Nora Berrah have been elected to the American Academy of Arts and Sciences, Class of 2019. (Peter Morenus/UConn Photos)

UConn Professors Elected to American Academy of Arts and Sciences

Dr. Cato Laurencin and physics professor Nora Berrah are among the academy's 239th class, along with former First Lady Michelle Obama, and other leaders.

UConn research was the cover story in a recent edition of the journal CrystEngComm.

Crystallizing Knowledge with a Learning Machine

UConn researchers working with Pfizer used machine learning to figure out the best way to coax a drug into solid form for the development of pharmaceuticals.

Ph.D. students Leila Daneshmandi and Armin Tahmasbi Rad, both from the Department of Biomedical Engineering, have developed a technology that takes a patient’s tumor cells and grows them outside of the body to test different cancer treatments. (Evan Olsen Photography)

New Technology Designed to Reduce Mortality Rates in Cancer Patients

A pair of Ph.D. students developed a technology that takes a patient’s tumor cells and grows them outside of the body to test different cancer treatments.

(Shutterstock)

Drug Discovery Partnership with AI Biotech Company Reaps Promising Early Results

At UConn Health, the technology is being used to pursue therapeutic treatments for strokes, for which there is “an urgent need for novel therapies that can move rapidly into clinical trials,” says Rajkumar Verma.

Prader Willi stem cells. (Yaling Liu/UConn Photo)

UConn and Foundation for Prader-Willi Research Create Stem Cell Biobank

The biobank will be able to supply induced-pluripotent stem cells for Prader-Willi syndrome to researchers throughout the world.

Dr. Eric Girard, a surgeon who specializes in colorectal surgery, with da Vinci Xi Robotic Surgery System. (Kristin Wallace/UConn Health Photo)

UConn Health Expands Robotic Surgery Capabilities

Dr. Eric Girard, a surgeon who specializes in colorectal surgery, says use of the new robot can translate to 'people feeling better faster and getting back to their families and their jobs sooner.'

Fighting the Opioid Epidemic With Data

UConn Health is part of a collaboration that aims to track crucial data and create an early warning system to alert the public to opioid overdoses.

Pharmaceutical sciences researcher Dennis Wright is developing new ways for antifolate medications to target the bacterium that causes TB. (Peter Morenus/UConn Photo)

Promising New Drugs for Old Pathogen TB

Pharmaceutical sciences researcher Dennis Wright is developing new ways for antifolate medications to target the bacterium that causes tuberculosis.

Shea Ralph with her daughter. (Frank Barton/UConn Health Photo)

New Mom Shea Ralph Chose UConn Health

In honor of National Doctors' Day this week, we spotlight the work of UConn Health's Ramzi Alkass.

Dr. Rajesh Lalla, professor of dental medicine; Diane Burgess, professor of pharmaceutical sciences; and Tingting Li, pharmaceutical graduate student. (Dr. Rajan Jog/UConn Photo)

New Therapy Targets Painful Side Effect of Cancer Treatment

Collaborators are close to replacing the 'sledge hammer' with a more precise and effective treatment option that doesn’t include risk of addiction or abuse.